In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative

The Journal of Antimicrobial Chemotherapy
Deborah C DraghiDaniel F Sahm

Abstract

Telavancin is a novel semi-synthetic lipoglycopeptide currently in late-stage clinical development for the treatment of serious infections due to Gram-positive bacteria. The objective of this study was to provide a baseline prospective assessment of its in vitro activity against a large and diverse collection of Gram-positive clinical isolates from Europe and Israel. Gram-positive clinical isolates, collected between October 2004 and December 2005 from 36 hospital laboratories in 15 countries, were tested by broth microdilution using CLSI methodology. In total, 3206 isolates were collected. Telavancin had potent activity against Staphylococcus aureus and coagulase-negative staphylococci (MIC range < or =0.015 to 2 mg/L), independent of resistance to methicillin or to multiple drugs. Telavancin had particularly strong activity against streptococcal isolates (MIC range < or =0.001 to 0.5 mg/L), including penicillin-resistant and multiple drug-resistant Streptococcus pneumoniae and erythromycin non-susceptible beta-haemolytic and viridans group streptococci. Telavancin also had excellent activity against vancomycin-susceptible enterococci (MIC(90) 0.5 mg/L), and although its MICs were elevated against VanA strains (Enterococcus fa...Continue Reading

References

Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D F SahmG Piazza
Apr 10, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James A KarlowskyUNKNOWN TRUST Surveillance Program
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·John L PaceKoné Kaniga
Dec 18, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel J DiekemaBradley N Doebbeling
May 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin E StryjewskiUNKNOWN FAST Investigator Group
Feb 24, 2006·Antimicrobial Agents and Chemotherapy·Martin E StryjewskiUNKNOWN FAST 2 Investigator Group
Aug 3, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H S SaderR N Jones
Jan 24, 2007·International Journal of Antimicrobial Agents·James E RossRonald N Jones
Jul 4, 2007·Antimicrobial Agents and Chemotherapy·W T M JansenD Milatovic

❮ Previous
Next ❯

Citations

Apr 30, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K SmithS Lang
Jan 22, 2009·The Journal of Antimicrobial Chemotherapy·Sharath S HegdeKevin M Krause
Sep 18, 2010·The Journal of Antimicrobial Chemotherapy·Michael A PfallerRonald N Jones
Apr 14, 2010·Antimicrobial Agents and Chemotherapy·Rodrigo E MendesRonald N Jones
Jul 22, 2009·Antimicrobial Agents and Chemotherapy·Klaudia Kosowska-ShickPeter C Appelbaum
Feb 18, 2010·Antimicrobial Agents and Chemotherapy·Gengrong LinPeter C Appelbaum
Jan 7, 2009·Antimicrobial Agents and Chemotherapy·G A Pankuch, P C Appelbaum
Apr 21, 2010·Antimicrobial Agents and Chemotherapy·Craig M HillJames W Janc
Jun 3, 2010·Antimicrobial Agents and Chemotherapy·Jeng-Pyng ShawMichael M Kitt
Dec 1, 2009·Drugs·Katherine A Lyseng-Williamson, Stephanie K A Blick
Oct 14, 2008·Expert Review of Anti-infective Therapy·Cesar A Arias, Barbara E Murray
Nov 1, 2009·Expert Review of Clinical Pharmacology·Knut Ohlsen
Apr 2, 2009·Expert Opinion on Investigational Drugs·Matteo BassettiClaudio Viscoli
May 12, 2012·Diagnostic Microbiology and Infectious Disease·Gengrong LinKlaudia Kosowska-Shick
Oct 11, 2011·International Journal of Antimicrobial Agents·Mamun-Ur RashidCarl Erik Nord
Aug 20, 2011·Diagnostic Microbiology and Infectious Disease·Rodrigo E MendesRonald N Jones
Mar 1, 2011·Diagnostic Microbiology and Infectious Disease·David J FarrellBret M Benton
Jul 20, 2010·Diagnostic Microbiology and Infectious Disease·Shannon D PutnamRonald N Jones
Aug 21, 2010·International Journal of Antimicrobial Agents·Tobias Welte, Mathias W Pletz
Sep 3, 2014·International Journal of Medical Microbiology : IJMM·Péter FeisztLevente Emődy
Jul 27, 2010·Pharmacotherapy·Michael R GoldbergSteven L Barriere
Dec 25, 2009·Pharmacotherapy·Michael R GoldbergSteven L Barriere
Sep 1, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James A KarlowskyGeorge G Zhanel
Nov 15, 2011·Expert Opinion on Pharmacotherapy·Ethan RubinsteinZeina A Kanafani
Oct 30, 2014·The Journal of Antibiotics·Venkateswarlu YarlagaddaJayanta Haldar
Dec 5, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G Ralph CoreySteven L Barriere
Apr 2, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G Cornaglia, G M Rossolini
Apr 30, 2009·The Annals of Pharmacotherapy·Lisa CharneskiDonna Sym
Jun 7, 2011·American Journal of Therapeutics·Kathryn A CulosShellee A Grim
Oct 30, 2014·The Annals of Pharmacotherapy·Ruchi Patel, Jason C Gallagher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved